Sphere-forming assays demonstrated that KO of BIM also significantly protected the cells against the combination-induced disruption of spheres (P<0.05 or less) in both BRAF and NRAS mutated melanoma cell lines (Figure 9C and 9D). This evidence concerns the gene BCL2L11 and melanoma.